Table 2. . Thirty-two candidate genes that differentially expressed between long- and short-term survivors in peripheral blood mononuclear cells prior to WT1 peptide vaccination in 30 glioblastoma multiforme patients in a discovery set.
| Gene | Fold change† | p-value‡ |
|---|---|---|
|
TLR10 |
0.85 |
0.051 |
|
KLHDC8B |
0.80 |
0.018 |
|
RALGPS2 |
0.80 |
0.017 |
|
CD79B |
0.71 |
0.029 |
|
TNFAIP8L2 |
0.69 |
0.026 |
| GCNT2 |
0.65 |
0.017 |
|
EVA1 |
0.64 |
0.022 |
|
CETN3 |
0.59 |
0.013 |
|
ROGDI |
0.58 |
0.012 |
|
CD82 |
0.57 |
0.004 |
|
IL17RA |
0.55 |
0.009 |
|
TNFSF14 |
-1.02 |
<0.001 |
|
CST1 |
-0.90 |
0.005 |
|
FBXO32 |
-0.90 |
0.021 |
|
ULBP2 |
-0.88 |
0.028 |
|
OASL |
-0.88 |
0.004 |
|
PHLDA1 |
-0.88 |
0.002 |
|
FASLG |
-0.86 |
0.028 |
|
XAGE5 |
-0.83 |
0.002 |
|
SDC4 |
-0.80 |
0.024 |
|
ZNF659 |
-0.79 |
0.003 |
|
SMAD7 |
-0.69 |
0.011 |
|
SLC7A5 |
-0.68 |
0.008 |
|
VPS37B |
-0.66 |
<0.001 |
|
HPGD |
-0.65 |
0.018 |
|
MLF1 |
-0.65 |
0.012 |
|
SKI |
-0.63 |
0.006 |
|
EXPH5 |
-0.63 |
0.009 |
|
ZC3H12A |
-0.61 |
0.007 |
|
UAP1 |
-0.57 |
0.015 |
|
CCNT1 |
-0.53 |
<0.001 |
| ITGA5 | -0.52 | 0.002 |
†Log2(long/short).
‡Two-tailed Welch's t-test.